- Home
- CUE vs LOOP Comparison
CUE vs LOOP Comparison
Compare CUE & LOOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CUE
- LOOP
- Stock Information
- Founded
- CUE 2014
- LOOP 2010
- Country
- CUE United States
- LOOP Canada
- Employees
- CUE 41
- LOOP N/A
- Industry
- CUE Biotechnology: Pharmaceutical Preparations
- LOOP Major Chemicals
- Sector
- CUE Health Care
- LOOP Industrials
- Exchange
- CUE Nasdaq
- LOOP Nasdaq
- Market Cap
- CUE 52.8M
- LOOP 63.9M
- IPO Year
- CUE 2018
- LOOP N/A
- Fundamental
- Price
- CUE $0.79
- LOOP $1.28
- Analyst Decision
- CUE Strong Buy
- LOOP
- Analyst Count
- CUE 3
- LOOP 0
- Target Price
- CUE $3.00
- LOOP N/A
- AVG Volume (30 Days)
- CUE 323.3K
- LOOP 191.7K
- Earning Date
- CUE 08-13-2025
- LOOP 07-22-2025
- Dividend Yield
- CUE N/A
- LOOP N/A
- EPS Growth
- CUE N/A
- LOOP N/A
- EPS
- CUE N/A
- LOOP N/A
- Revenue
- CUE $7,991,000.00
- LOOP $10,889,000.00
- Revenue This Year
- CUE N/A
- LOOP N/A
- Revenue Next Year
- CUE $23.84
- LOOP $592.45
- P/E Ratio
- CUE N/A
- LOOP N/A
- Revenue Growth
- CUE 13.83
- LOOP 7016.99
- 52 Week Low
- CUE $0.45
- LOOP $0.85
- 52 Week High
- CUE $1.99
- LOOP $2.29
- Technical
- Relative Strength Index (RSI)
- CUE 51.10
- LOOP 43.51
- Support Level
- CUE $0.65
- LOOP $1.05
- Resistance Level
- CUE $0.83
- LOOP $1.25
- Average True Range (ATR)
- CUE 0.07
- LOOP 0.15
- MACD
- CUE 0.01
- LOOP -0.05
- Stochastic Oscillator
- CUE 30.43
- LOOP 27.94
About CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.
About LOOP Loop Industries Inc.
Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.